Powell Andrew Kenneth William 4
4 · Silverback Therapeutics, Inc. · Filed Jun 13, 2022
Insider Transaction Report
Form 4
Powell Andrew Kenneth William
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-10+18,000→ 18,000 totalExercise: $4.18Exp: 2032-06-09→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest on the earlier of June 10, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.